Analysis of Reporting of Cutaneous Toxicities Associated With Immune Checkpoint Inhibitors

NCT04898751 · clinicaltrials.gov ↗

COMPLETED

Status

2214

Enrollment

OTHER

Sponsor class

Conditions

Cutaneous Toxicity From ICI Therapy

Interventions

DRUG: Immune checkpoint inhibitor (ICI)

Sponsor

Johns Hopkins University